Table 2 Disease risk perception and ethical aspects regarding cohort participation based on visual analog scale
RA-risk cohort | SpA-risk cohort | |
|---|---|---|
Q8 The thought of developing RA/SpA preoccupies me | 4 (2–6) | 3 (1–5) |
Q9 I am certain that I will develop RA/SpA | 3 (1–5) | 3 (1–5) |
Q10 RA/SpA is a severe disease | 6.5 (5–8) | 6 (4–8) |
Q11 I am worried that I have an increased risk of developing RA/SpA | 5 (2–6) | 3 (1–5) |
Q12 By participating in this research, I feel that I am extra confronted with the fact that I have an increased risk to develop RA/SpA | 2 (1–5) | 1.5 (1–4) |
Q13 How objectionable is it for you to be extra confronted with the risk to develop RA/SpA by participation in this cohort? | 1 (0–2) | 1 (0–1) |
Q14 By participating in this research there is more attention for my complaints | 6 (2–8) | 4.5 (1–5.25) |
Q15 I think that by participating in this study I will receive earlier and better medical care upon RA/SpA development than if I did not participate in this study | 7 (5–8) | 7.5 (6–9) |